Skip to main content
. 2024 Sep 5;32(10):636. doi: 10.1007/s00520-024-08803-w

Table 2.

Participant demographics

Gender – female, n (%) 13 (59)
Age (mean, SD) 64 (16)
Ethnicity, n (%)
Caucasian 19 (86)
Asian 3 (14)
Diagnosis, n (%)
Breast 9 (41)
Prostate 3 (14)
AML 2 (9)
Lymphoma 2 (9)
Other haematological malignancy 4 (18)
Other solid malignancy 2 (9)
Disease stage n (%)
Early (0–III) 10 (45)
Advanced (IV) 4 (18)
Unknown 8 (36)
Receiving chemotherapy treatment 17 (77)
Total, n 22